Health Catalyst executives will present at the J.P. Morgan Healthcare Conference on January 15, 2025.
Quiver AI Summary
Health Catalyst, a leading provider of data and analytics technology for healthcare organizations, announced that its executives will participate in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, including a presentation scheduled for January 15, 2025, at 10:30 am PT. The event will feature CEO Dan Burton, CFO Jason Alger, COO Dan LeSueur, and VP of Investor Relations Jack Knight. Interested parties can access the webcast and presentation materials on their investor relations website. Health Catalyst aims to drive significant improvements in healthcare through data-informed decisions, utilizing their cloud-based platform and expertise derived from over 100 million patient records.
Potential Positives
- Health Catalyst will present at the prestigious 43rd Annual J.P. Morgan Healthcare Conference, enhancing visibility and credibility among investors and industry leaders.
- The participation of key executives highlights the company's commitment to engaging stakeholders and sharing its vision for data-informed healthcare improvements.
- The webcast and presentation materials will be accessible online, allowing a wider audience to engage with the company’s insights and developments.
Potential Negatives
- None
FAQ
What is the 43rd Annual J.P. Morgan Healthcare Conference?
The J.P. Morgan Healthcare Conference is a major event where healthcare companies share insights and innovations with investors and industry leaders.
When will Health Catalyst present at the conference?
Health Catalyst will present on Wednesday, January 15, 2025, at 10:30 am PT during the conference.
Who is participating in the Health Catalyst presentation?
Dan Burton, Jason Alger, Dan LeSueur, and Jack Knight will participate in the Health Catalyst presentation.
Where can I find the webcast and presentation materials?
The webcast link and related presentation materials will be available online at https://ir.healthcatalyst.com.
What services does Health Catalyst provide to healthcare organizations?
Health Catalyst provides data and analytics technology, services, and a cloud-based platform for informed decision-making in healthcare.
Disclaimer: This is an AI-generated summary of a press release distributed by GlobeNewswire. The model used to summarize this release may make mistakes. See the full release here.
$HCAT Insider Trading Activity
$HCAT insiders have traded $HCAT stock on the open market 18 times in the past 6 months. Of those trades, 0 have been purchases and 18 have been sales.
Here’s a breakdown of recent trading of $HCAT stock by insiders over the last 6 months:
- DANIEL LESUEUR (Chief Operating Officer) has traded it 6 times. They made 0 purchases and 6 sales, selling 51,745 shares.
- KEVIN LEE FREEMAN (Chief Commercial Officer) has traded it 3 times. They made 0 purchases and 3 sales, selling 22,500 shares.
- LINDA LLEWELYN (Chief People Officer) has traded it 6 times. They made 0 purchases and 6 sales, selling 7,921 shares.
- BENJAMIN LANDRY (General Counsel) sold 2,466 shares.
- JASON ALGER (Chief Financial Officer) has traded it 2 times. They made 0 purchases and 2 sales, selling 5,722 shares.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$HCAT Hedge Fund Activity
We have seen 75 institutional investors add shares of $HCAT stock to their portfolio, and 104 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- NEPSIS INC. added 851,448 shares (+67.9%) to their portfolio in Q3 2024
- INVENOMIC CAPITAL MANAGEMENT LP removed 850,581 shares (-100.0%) from their portfolio in Q3 2024
- FRED ALGER MANAGEMENT, LLC added 842,509 shares (+inf%) to their portfolio in Q3 2024
- JACOBS LEVY EQUITY MANAGEMENT, INC removed 688,905 shares (-86.0%) from their portfolio in Q3 2024
- MILLENNIUM MANAGEMENT LLC removed 686,441 shares (-28.4%) from their portfolio in Q3 2024
- PORTOLAN CAPITAL MANAGEMENT, LLC added 663,602 shares (+inf%) to their portfolio in Q3 2024
- IMPAX ASSET MANAGEMENT GROUP PLC added 360,201 shares (+16.4%) to their portfolio in Q3 2024
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
Full Release
SALT LAKE CITY, Dec. 10, 2024 (GLOBE NEWSWIRE) -- Health Catalyst, Inc. ("Health Catalyst", Nasdaq: HCAT), a leading provider of data and analytics technology and services to healthcare organizations, today announced that Dan Burton, Chief Executive Officer, Jason Alger, Chief Financial Officer, Dan LeSueur, Chief Operating Officer, and Jack Knight, Vice President of Investor Relations, will participate in the 43rd Annual J.P. Morgan Healthcare Conference in San Francisco, including a presentation on Wednesday, January 15, 2025, at 10:30 am PT. The webcast link and related presentation materials will be available online at https://ir.healthcatalyst.com .
About Health Catalyst
Health Catalyst is a leading provider of data and analytics technology and services to healthcare organizations and is committed to being the catalyst for massive, measurable, data-informed healthcare improvement. Its clients leverage the cloud-based data platform—powered by data from more than 100 million patient records and encompassing trillions of facts—as well as its analytics software and professional services expertise to make data-informed decisions and realize measurable clinical, financial, and operational improvements. Health Catalyst envisions a future in which all healthcare decisions are data informed.
Health Catalyst Investor Relations Contact:
Jack Knight
Vice President, Investor Relations
+1 (855) 309-6800
[email protected]
Health Catalyst Media Contact:
Amanda Flanders
Senior Vice President, Marketing and Communications
[email protected]
